# Bariatric Surgery vs Semaglutide for Cardiovascular Events: 18,793 Matched Pairs

The matched study compared recorded heart and vascular events after bariatric surgery or semaglutide initiation, with results separated by type 2 diabetes.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/surgery-won-this-comparison-clearly
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Bariatric Surgery vs Semaglutide for Cardiovascular Events: 18,793 Matched Pairs

In 18,793 matched pairs, bariatric surgery was associated with fewer recorded cardiovascular events than starting semaglutide. The comparison used retrospective records.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20267 min readUpdated November 2026

Cardiovascular events, up to 5 years · surgery · semaglutide · without diabetes · 4.4% · 6.6% · with diabetes · 9% · 14.6% · Observed event proportions during follow-up

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   Researchers compared adults with obesity who had bariatric surgery or started semaglutide.
-   Recorded cardiovascular events were less common after surgery in both diabetes groups.
-   Treatment selection and differences in follow-up limit what this retrospective study can establish.

This TriNetX study compared people starting semaglutide with people undergoing sleeve gastrectomy or gastric bypass [\[1\]](https://buythisglp.com/research/surgery-won-this-comparison-clearly#ref-1). The [cost comparison for GLP-1 treatment and bariatric surgery](https://buythisglp.com/research/is-a-glp1-cheaper-than-bariatric-surgery) addresses a separate decision. The study measured a combined outcome of coronary events, cerebrovascular events, heart failure and cardiac arrest.

## What were the event rates?

Researchers matched 11,466 pairs without type 2 diabetes and 7,327 pairs with it. During follow-up of up to five years, the recorded rates without diabetes were 4.4% after surgery and 6.6% with semaglutide. The hazard ratio was 0.402 (95% CI 0.356–0.454)[\[1\]](https://buythisglp.com/research/surgery-won-this-comparison-clearly#ref-1). With diabetes, the recorded rates were 9.0% and 14.6% respectively. The hazard ratio was 0.421 (95% CI 0.381–0.465) [\[1\]](https://buythisglp.com/research/surgery-won-this-comparison-clearly#ref-1).

## Can matching explain the difference?

Matching balanced measured characteristics. Surgical eligibility and other unmeasured differences could still affect the comparison. Research on [how long people stay on GLP-1 treatment](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1) also helps explain why starting treatment is different from taking it throughout follow-up. The authors varied refill requirements in sensitivity analyses, and the direction of the results stayed consistent [\[1\]](https://buythisglp.com/research/surgery-won-this-comparison-clearly#ref-1).

## Frequently asked

How large was the observed difference?

The raw event proportions differed by 2.2 percentage points without diabetes and 5.6 with diabetes during follow-up of up to five years.

Does this show surgery prevents more cardiovascular events?

The study found an association. Matching could not account for all differences between people choosing or eligible for each treatment.

## Sources

1.  \[1\] Tseng TC, Ssu-Yu Chen S, Chen HY, Chang R (2026). Semaglutide vs Metabolic and Bariatric Surgery and Cardiovascular Outcomes in Obesity Endocrine Practice. [PMID 42580629](https://pubmed.ncbi.nlm.nih.gov/42580629/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
